Tenofovir Modulates Semaphorin 4D Signaling and Regulates Bone Homeostasis, Which Can Be Counteracted by Dipyridamole and Adenosine A2A Receptor
Semaphorin 4D (Sema4D) is a neurotrophin that is secreted by osteoclasts and binds to its receptor PlexinB1 on osteoblasts to inhibit their differentiation and function. Adenosine A2A activation inhibits osteoclast Sema4D-mediated secretion, diminishes inflammatory osteolysis and prevents bone loss...
Saved in:
Main Authors: | Patricia Llamas-Granda, Laura Martin-Rodríguez, Raquel Largo, Gabriel Herrero-Beaumont, Aránzazu Mediero |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/73f8e5acad59435e9fc5b741753ed5da |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study
by: Pei-Yuan Su, et al.
Published: (2021) -
Semaphorin 3A mitigates lipopolysaccharide-induced chondrocyte inflammation, apoptosis and extracellular matrix degradation by binding to Neuropilin-1
by: Huiyu Zhang, et al.
Published: (2021) -
Tenofovir induced lichenoid drug eruption
by: Mrinal Gupta, et al.
Published: (2015) -
APPLICATION OF HIGH-PERFORMANCE THIN-LAYER CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS DETERMINATION OF LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE IN PHARMACEUTICAL DOSAGE FORM
by: CHANDRA,P, et al.
Published: (2011) -
Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy
by: Rafael Franco, et al.
Published: (2021)